GPCR39 pepducins (Anchor/Janssen)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGPCR39 pepducins (Anchor/Janssen)
Drug Alias NameGPCR39 pepducins (Anchor Therapeutics)GPCR39 pepducins (Anchor Therapeutics/Ortho-McNeil-Janssen)G-protein coupled receptor-39 modulators (Anchor Therapeutics)
ClassificationBiologics
Mechanisms of ActionG-protein coupled receptor 39 modulators
TargetsG-protein coupled receptor 39
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnchor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncAnchor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A